PFA Reg 30 Disclosure of SEBI LODR

AJANTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+5.9%1-day move

₹2900.00

prior close

₹2958.10

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.2+0.6+0.6+1.6+5.9+4.6+5.2+6.4+7.8+9.6+4.3+2.4+16.4—

Up moveDown movePending

AI summary

Ajanta Pharma Limited has disclosed routine auditor re-appointments approved at its Board meeting on 5th May 2026. The company re-appointed three audit firms for FY 2026-27: Aneja Assurance Pvt. Ltd. as Internal Auditors, M/s. RA & Co. as Cost Auditors, and M/s. R S Sanghai & Associates as Tax Auditors. The Cost Auditors' appointment is subject to shareholder ratification. All re-appointments are standard annual procedures with no changes in auditors.

Likely market impact

This is a routine corporate governance disclosure with no material impact on shareholders. The company maintains its existing audit relationships with no red flags.